Form 8-K - Current report:
SEC Accession No. 0001213900-22-081972
Filing Date
2022-12-22
Accepted
2022-12-22 09:00:17
Documents
12
Period of Report
2022-12-16
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea170679-8k_nektar.htm   iXBRL 8-K 22836
  Complete submission text file 0001213900-22-081972.txt   193491

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE nktr-20221216.xsd EX-101.SCH 3221
3 XBRL LABEL FILE nktr-20221216_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE nktr-20221216_pre.xml EX-101.PRE 22355
6 EXTRACTED XBRL INSTANCE DOCUMENT ea170679-8k_nektar_htm.xml XML 3489
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

EIN.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24006 | Film No.: 221480036
SIC: 2834 Pharmaceutical Preparations